Orphazyme A/S
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Orphazyme A/S (OZYMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.000x
Based on the latest financial reports, Orphazyme A/S (OZYMF) has a cash flow conversion efficiency ratio of 0.000x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.63K) by net assets ($18.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Orphazyme A/S - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Orphazyme A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Orphazyme A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orphazyme A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
C.H.ROBINSON WLDWDE - Dusseldorf Stock Exchang
DU:CH1A
|
0.066x |
|
Mystic Holdings Inc.
OTCQB:MSTH
|
N/A |
|
BSF Enterprise Plc
PINK:BSFAF
|
-0.092x |
|
BioRestorative Therapies Inc
NASDAQ:BRTX
|
-1.315x |
|
C.H.ROBINSON WLDWDE
HM:CH1A
|
0.066x |
|
RH Inc.
BE:RS1
|
-0.048x |
|
Noratis AG
XETRA:NUVA
|
0.070x |
|
ISC Fresh Water Investment SOCIMI SA
MC:YISC
|
0.126x |
Annual Cash Flow Conversion Efficiency for Orphazyme A/S (2014–2024)
The table below shows the annual cash flow conversion efficiency of Orphazyme A/S from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $19.25 Million | $-3.36 Million | -0.175x | +87.58% |
| 2023-12-31 | $14.24 Million | $-20.02 Million | -1.406x | -48736.40% |
| 2022-12-31 | $40.97 Million | $-117.94K | -0.003x | +100.00% |
| 2021-12-31 | $9.34 Million | $-602.57 Million | -64.522x | -7327.06% |
| 2020-12-31 | $620.52 Million | $-539.08 Million | -0.869x | +85.92% |
| 2019-12-31 | $52.97 Million | $-326.82 Million | -6.170x | -920.38% |
| 2018-12-31 | $388.25 Million | $-234.76 Million | -0.605x | -290.14% |
| 2017-12-31 | $615.70 Million | $-95.43 Million | -0.155x | +95.04% |
| 2016-12-31 | $17.51 Million | $-54.73 Million | -3.126x | -399.30% |
| 2015-12-31 | $74.14 Million | $-46.41 Million | -0.626x | -53.56% |
| 2014-12-31 | $89.38 Million | $-36.44 Million | -0.408x | -- |